The role of IL-17 on RA has been extensively studied [7,12,13]; therefore, this review will focus on the role of IL-17 in the pathogenesis of other systemic rheumatic diseases, mainly SLE, SS and SSc, as well as the potential therapeutic intervention on these diseases. This evidence concerns the gene IL17A and systemic lupus erythematosus.